Frank Rimerman Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Frank Rimerman Advisors's IONS Position: Q2 2026 in Review
Frank Rimerman Advisors increased its Ionis Pharmaceuticals (IONS) stake by 0.45% in Q2 2026, buying an estimated $1.96K and bringing the position to 5,807 shares worth $460K. The position accounts for 0.03% of the portfolio, ranked #428.
Frank Rimerman Advisors first reported a position in IONS in Q2 2025 and has held it in 5 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- Frank Rimerman Advisors held 5,807 shares of Ionis Pharmaceuticals worth $460K as of Q2 2026.
- Frank Rimerman Advisors bought 26 Ionis Pharmaceuticals shares in Q2 2026, an estimated $1.96K.
- Ionis Pharmaceuticals made up 0.03% of Frank Rimerman Advisors's portfolio in Q2 2026, its #428 holding.
- Frank Rimerman Advisors first reported a position in Ionis Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.